The effect of GLP-1RA on the eGFR-related endpoint worsening kidney function was neutral in the main analysis (HR 0.86, 95% CI 0.721.02), while a statistically significant benefit was detected in the sensitivity analysis excluding ELIXA (HR 0.82, 95% CI 0.690.98) [11]
What is the difference between IGF-1 LR3 and sermorelin or CJC-1295
This product is not intended to diagnose, treat, prevent, or cure any disease
Maintenance and prevention protocol Lower-dose combination approaches support ongoing tissue health and injury prevention in active individuals with chronic tissue demands
These include reduction of systolic and diastolic blood pressure, body weight, vascular inflammation, and improvement of endothelial function [55,56,57,58]